Illumina right tells Roche to 'BOGOF'
This article was originally published in Scrip
Executive Summary
Gene sequencing specialist Illumina has launched a "poison pill" defence against Roche's attempted hostile takeover by adopting a shareholders' rights agreement that will serve to dilute the company's stock.